Beacon Capital Management LLC (Tennessee)’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$211K Sell
8,742
-1,886
-18% -$49.3K 0.03% 161
2026
Q1
$298K Buy
10,628
+263
+3% +$7K 0.05% 130
2025
Q4
$258K Buy
10,365
+473
+5% +$11.9K 0.04% 130
2025
Q3
$252K Sell
9,892
-518
-5% -$12.8K 0.04% 115
2025
Q2
$252K Sell
10,410
-465
-4% -$10.8K 0.03% 112
2025
Q1
$276K Sell
10,875
-183
-2% -$4.79K 0.04% 105
2024
Q4
$293K Sell
11,058
-1,120
-9% -$30.4K 0.04% 97
2024
Q3
$352K Buy
12,178
+1,402
+13% +$40.9K 0.05% 81
2024
Q2
$302K Sell
10,776
-34
-0.3% -$936 0.06% 78
2024
Q1
$300K Buy
10,810
+183
+2% +$5.08K 0.06% 73
2023
Q4
$352K Sell
10,627
-696
-6% -$21K 0.1% 53
2023
Q3
$415K Hold
11,323
0.11% 50
2023
Q2
$415K Buy
11,323
+542
+5% +$21.1K 0.11% 50
2023
Q1
$440K Sell
10,781
-389
-3% -$16.8K 0.13% 50
2022
Q4
$572K Buy
11,170
+404
+4% +$19.4K 0.19% 42
2022
Q3
$565K Sell
10,766
-16
-0.1% -$777 0.19% 39
2022
Q2
$558K Hold
10,782
0.14% 48
2022
Q1
$558K Buy
+10,782
New +$559K 0.13% 48

Other funds holding PFE

Beacon Capital Management LLC (Tennessee)'s PFE Position: Q2 2026 in Review

Beacon Capital Management LLC (Tennessee) reduced its Pfizer (PFE) stake by 18% in Q2 2026, selling an estimated $49.3K and leaving 8,742 shares worth $211K. The position accounts for 0.03% of the portfolio, ranked #161.

Beacon Capital Management LLC (Tennessee) first reported a position in PFE in Q1 2022 and has held it in 18 quarters since. The position peaked at $572K in Q4 2022. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Beacon Capital Management LLC (Tennessee) held 8,742 shares of Pfizer worth $211K as of Q2 2026.
  • Beacon Capital Management LLC (Tennessee) sold 1,886 Pfizer shares in Q2 2026, an estimated $49.3K.
  • Pfizer made up 0.03% of Beacon Capital Management LLC (Tennessee)'s portfolio in Q2 2026, its #161 holding.
  • Beacon Capital Management LLC (Tennessee) first reported a position in Pfizer in Q1 2022 and has held it in 18 quarters since.
  • Beacon Capital Management LLC (Tennessee)'s Pfizer position peaked at $572K in Q4 2022.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Beacon Capital Management LLC (Tennessee)'s 13F filing for Q2 2026, filed 29 Jul 2026.